COMMUNIQUÉS West-GlobeNewswire

Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer
28/10/2026
Company Announcement COPENHAGEN, Denmark; October 28, 2026 Phase 3 LiGeR-HN1 trial of Petosemtamab in combination with pembrolizumab versus pembrolizumab alone met both primary endpoints, reducing the risk of death by [...]
Applied Biologics Announces Publication of Peer-Reviewed CAMPX Interim Trial Results in the Journal of Chronic Wound Care Management & Research
28/10/2026
Published multicenter clinical trial data demonstrate higher wound closure rates and greater wound area reduction with XWRAP® plus standard of care compared with standard of care alone in patients with chronic diabetic [...]
Vivex Biologics' VIA Disc® NP Meets Primary Endpoint in Pivotal, Sham-Controlled ASCEND Trial Published in Journal of Clinical Medicine
28/10/2026
The first intradiscal allograft to succeed in a rigorous, sham-controlled trial for chronic lumbar discogenic pain, a leading driver of the world’s #1 cause of disability MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Vivex [...]
Longeveron Announces Engagement of Lucid Capital Markets
28/10/2026
MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (the “Company”) (NASDAQ: LGVN), today announced that the Company has retained Lucid Capital Markets, LLC as the Company’s financial advisor to explore potential [...]
Digital Wellness Launches Protein Calculator for Mayo Clinic Diet to End the Guesswork Around Daily Protein Needs
28/10/2026
New online and in-app feature applies nutrition science to generate personalized protein recommendations BROOKLYN, New York, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Digital Wellness , the leading behavioral change platform [...]
Athelas Named Diamond Sponsor of the 2026 APTA Private Practice Annual Conference, Deepening Its Commitment to the Physical Therapy Profession
28/10/2026
CEO Tanay Tandon will open the keynote session and welcome APTA Private Practice President Mike Horsfield and a special guest to the stage MOUNTAIN VIEW, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Athelas , powered by [...]
Manta Cares and Cancer Support Community SF Bay Area Partner to Bring AI-Powered Cancer Support to Northern California Patients and Families
28/10/2026
Partnership pairs Hope AI™, Manta Cares' AI partner built with patients and oncologists, with CSC SFBA's community programs so people in treatment can find personalized support at any hour WALNUT CREEK, Calif. and SAN [...]
Nelipak Healthcare Packaging Awarded Silver Medal Sustainability Rating from EcoVadis
28/10/2026
Nelipak Ranked Among the Top 15% of Surveyed Companies CRANSTON, R.I., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Nelipak ® Corporation (“Nelipak ® ”), a leading global provider of healthcare packaging solutions announced it has [...]
Arcutis Appoints Rob Scott, MD to Board of Directors
28/10/2026
WESTLAKE VILLAGE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovation in immuno-dermatology, [...]
LiveWorld Appoints Rema Judeh as Vice President of Account Management
28/10/2026
Pharma marketing agency leader joins LiveWorld to deepen client partnerships and build creative, moderation, and intelligence system revenues CAMPBELL, Calif. and NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- LiveWorld, [...]
Biosphere Secures $21 Million Department of War Contract for Biomanufacturing of Critical Chemicals
28/10/2026
Funding will support industrial-scale production technology designed to reduce reliance on foreign supply chains for chemicals and materials. OAKLAND, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Biosphere, a developer of [...]
Houston VA Study Reports Increased Quantitative Monitoring with TwitchView®; Separate Study Shows Near-Zero Bias Versus Gold Standard Mechanomyography, Both Presented at ANESTHESIOLOGY® 2026
28/10/2026
SEATTLE, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Blink Anesthesia, maker of the TwitchView ® quantitative neuromuscular monitor, highlights two studies presented at ANESTHESIOLOGY ® 2026, the annual meeting of the American [...]
Noom Study Finds Members Further Along in Its GLP-1Rx Program Report Higher “Flourishing” and “Quality of Life”
28/10/2026
Analysis of 1,259 members of Noom’s GLP-1Rx Program finds clinically meaningful differences in anxiety, depression, fatigue, pain, cognition, social participation and overall health-related quality of life at Day 145 [...]
Annexon to Host Virtual Investor Event on November 3, 2026: Vonaprument for the Treatment of Geographic Atrophy - Highlighting Key Aspects of Phase 3 ARCHER II Trial
28/10/2026
BRISBANE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)
28/10/2026
Submission backed by clinical data from two clinical studies representing 168 subjects demonstrating quality of life improvements and an approximately 40% reduction in neuropathic pain scores in the active treatment [...]
Sofwave to Participate in Upcoming November Investor Conferences
28/10/2026
SAN CLEMENTE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today [...]
Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
28/10/2026
Findings provide new insight into simufilam’s effects on cellular stress responses and mitochondrial function New research demonstrates a 37% reduction in elevated ATF4, consistent with attenuation of the ATF4- [...]
Immutep Receives A$2.16 million French R&D Tax Incentive
28/10/2026
SYDNEY, AUSTRALIA, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage immunotherapy company targeting cancer and autoimmune diseases, today [...]
Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
28/10/2026
• 135 patients, out of a total planned 182, have been randomized and were administered the first injection of Allocetra TM ; enrollment actively ongoing at clinical sites in the United States and in Europe • Topline six [...]

Pages